Glucagon may regulate FFA metabolism in vivo. To test this hypothesis,
six healthy male volunteers were infused with somatostatin, to inhibi
t endogenous hormone secretion, and insulin, glucagon, and GH to repla
ce endogenous secretion of these hormones. In the hypoglucagonemia exp
eriments, the glucagon infusion was omitted, and in the hyperglucagone
mic experiments glucagon was infused at 1.3 ng/kg.min, to produce phys
iological hyperglucagonemia. In two sets of control experiments, gluca
gon was infused at 0.65 ng/kg.min, in order to maintain peripheral eug
lucagonemia, and the plasma glucose concentrations were clamped at the
levels observed in either the hypo- or hyperglucagonemic experiments.
Rates of FFA and glycerol (an index of lipolysis) appearance (Ra) wer
e estimated with the isotope dilution method using [1-C-14]palmitate a
nd [H-2(5)] glycerol. Plasma glucagon concentrations decreased during
the hypoglucagonemic experiments (85 +/- 12 vs. 123 +/- 22 ng/L, P < 0
.05) and increased during the hyperglucagonemic experiments (186 +/- 2
0 vs. 125 +/- 15 ng/L, P < 0.05), whereas other hormone concentrations
remained the same. Hypoglucagonemia resulted in equivalent suppressio
n of FFA Ra (3.7 +/- 0.2 vs. 5.9 vs. 0.3 mumol/kg.min, P < 0.01) and g
lycerol Ra (1.2 +/- 0.2 vs. 2.2 +/- 0.5 mumol/kg.min, P < 0.05). Simil
arly, hyperglucagonemia resulted in equivalent stimulation of FFA Ra (
5.2 +/- 0.4 vs. 3.7 +/- 0.3 mumol/kg.min, P < 0.05) and glycerol Ra (1
.5 +/- 0.3 vs. 1.1 +/- 0.1 mumol/kg.min, P < 0.05). These results indi
cate that glucagon has a physiological role in the regulation of FFA m
etabolism in vivo.